glp-1 agonists for diabetes How Receptor Evolved from to Weight Loss Treatments Study finds GLP-1 receptor agonists
Description
Wang Y, Wang J, Gong Q, et al
A market can show strong starts while long-term continuation remains fragile
A notable limitation of the current study is the potential presence of residual confounding
In addition, weight loss is a consistent finding in clinical trials investigating GLP-1RAs ( Reduction of hepatic and adipose tissue insulin resistance An improved insulin sensitivity is expected after chronic treatment with GLP-RAs mainly due to marked bodyweight reductions
Furthermore, cardiovascular and renal disease are the predominant cause of premature mortality in type 1 diabetes [13]
Effect of weight loss on upper airway anatomy and the apnea-hypopnea index
